Aandeel BHC BAUSCH HEALTH COMPANIES INC.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Bausch Health Companies Inc.

Aandelen

BHC

CA0717341071

Geschatte realtime Cboe BZX
Andere beurzen
 16:12:46 26-04-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
8,67 USD +0,58% Intraday-grafiek van Bausch Health Companies Inc. -0,23% +8,10%
23/04 Bausch Health in "sterkere positie" voor Bausch + Lomb distributie, zegt RBC MT
23/04 RBC geeft voorbeschouwing op Q1 van Bausch Health, verlaagt koersdoel naar US$11 MT

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Bausch + Lomb Reports "Statistically Significant" Results From Study of Nutritional Supplement for Dry Eyes
Bausch + Lomb Brief: Announcing "Statistically Significant" Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry Eyes
Bausch Health in 'Stronger Position' for Bausch + Lomb Distribution, RBC Says
RBC Previews Bausch Health's Q1, Trims Target to US$11
RBC Cuts Bausch + Lomb Target to US$18, Reiterates Outperform, as Previews Q1
Bausch Health's Issuer Credit Rating Upgraded by S&P
Bausch Health Gets 'Positive' Court Ruling on Xifaxan With Market Odds of Bausch + Lomb Distribution at 32%, RBC Says
RBC Notes "Positive" Appellate Court Ruling For Bausch Health, But Thinks Market Assigning ~32% BLCO Distribution Odds
Bausch Health, Canada Inc. - Acne vulgaris treatment PrARAZLO now available to patients through British Columbia PharmaCare public drug plan
Bausch Health Companies - Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich's Abbreviated New Drug Application Until 2029
Bausch Health to Announce First-Quarter 2024 Results on May 2
Bausch wins US appeal to block Alvogen generic of diarrhea drug
Canadian Investment Regulatory Organization Trade Resumption - BHC
Canadian Investment Regulatory Organization Trading Halt - BHC
Bausch Health, Canada Inc. Announces Acne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan
TSX ends flat as gold stocks drop, mood cautious ahead of rate decision
Bausch Health Up Near 0.4% In US Premarket After Announcing Patent Lawsuit Against Amneal Pharmaceuticals
North American Morning Briefing : Inflation Data, -2-
Trump eyes $43 million haul from biggest fundraiser yet
RBC Raises Bausch Health Target to US$12, Maintains Sector Perform, on Upcoming Xifaxan Litigation Ruling
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers BHC
  4. Nieuws Bausch Health Companies Inc.
  5. Andere talen